European Medical Solutions (EBR:ALEMS)

EBR:ALEMS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.08	4.89	4.58	4.2	4.23	2.43
Cash & Short-Term Investments	3.08	4.89	4.58	4.2	4.23	2.43
Cash Growth	7.66%	6.80%	8.95%	-0.76%	74.37%	-14.87%
Accounts Receivable	14.3	12.02	8.01	5.98	6.14	6.53
Other Receivables	1.95	1.54	1.04	1.32	1.16	1.36
Receivables	16.25	13.57	9.05	7.3	7.3	7.89
Inventory	12.67	14.22	13.02	14.36	13.05	11.56
Prepaid Expenses	0.53	0.41	0.12	0.24	0.59	0.41
Other Current Assets	2.3	3.42	7.44	4.75	2.32	1.69
Total Current Assets	34.82	36.51	34.21	30.84	27.49	23.98
Property, Plant & Equipment	3.46	3.91	4.49	5.09	5.49	5.85
Long-Term Investments	0.03	0.03	0.03	0.03	0.03	0.03
Other Intangible Assets	0.62	0.51	0.56	0.63	0.29	0.29
Long-Term Deferred Charges	11.4	10.65	9	7	6.43	5.98
Other Long-Term Assets	0.25	0.19	0.19	0.17	0.16	0.17
Total Assets	50.58	51.79	48.47	43.76	39.89	36.3

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.67	12.91	10.29	9.3	9.39	6.56
Accrued Expenses	1.94	1.57	1.78	1.58	2.39	3.1
Short-Term Debt	2.62	5.29	3.88	3.78	1.34	3.2
Current Portion of Long-Term Debt	2.76	2.91	3.84	1.64	2.54	0.49
Current Portion of Leases	0.7	0.71	0.66	0.64	0.57	0.64
Current Income Taxes Payable	0.24	0.57	0.31	0.48	0.44	0.45
Current Unearned Revenue	0.19	0.71	0.03	0.37	0.12	0.37
Other Current Liabilities	1.41	1.32	1.57	1.54	1.41	0.55
Total Current Liabilities	20.53	25.99	22.36	19.33	18.19	15.36
Long-Term Debt	11.43	6.64	7.97	8.75	6.06	4.5
Long-Term Leases	1.75	3.12	3.51	3.97	4.28	4.67
Long-Term Unearned Revenue	2.37	2.37	2.37	1.59	0.53	0.53
Pension & Post-Retirement Benefits	0.36	0.34	0.29	0.23	0.2	-
Other Long-Term Liabilities	0.99	1.27	1.64	-	-	0.35
Total Liabilities	37.43	39.73	38.14	33.87	29.25	25.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13.15	12.06	10.34	9.82	10.56	10.81
Total Common Equity	13.15	12.06	10.34	9.82	10.56	10.81
Minority Interest	-	-	-	0.08	0.08	0.09
Shareholders' Equity	13.15	12.06	10.34	9.89	10.64	10.89
Total Liabilities & Equity	50.58	51.79	48.47	43.76	39.89	36.3

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19.25	18.68	19.85	18.77	14.79	13.5
Net Cash (Debt)	-16.18	-13.79	-15.27	-14.57	-10.56	-11.07
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.82	-3.26	-3.61	-3.44	-2.49	-161.75
Filing Date Shares Outstanding	4.23	4.23	4.23	4.23	4.23	4.23
Total Common Shares Outstanding	4.23	4.23	4.23	4.23	4.23	0.06
Working Capital	14.28	10.52	11.84	11.51	9.3	8.62
Book Value Per Share	3.11	2.85	2.44	2.32	2.50	173.73
Tangible Book Value	12.53	11.55	9.78	9.19	10.27	10.51
Tangible Book Value Per Share	2.96	2.73	2.31	2.17	2.43	169.03
Machinery	2.73	2.77	2.7	2.81	3.08	2.58
Construction In Progress	-	-	0.05	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 19, 2026

Data Sources Report a data error